REVERSIBLE AND IRREVERSIBLE INACTIVATION OF PREFORMED PULMONARY SURFACTANT SURFACE-FILMS BY CHANGES IN SUBPHASE CONSTITUENTS

被引:32
作者
AMIRKHANIAN, JD
TAEUSCH, HW
机构
[1] DREW UNIV, KING DREW MED CTR, DEPT PEDIAT, 12021 S WILMINGTON AVE, LOS ANGELES, CA 90059 USA
[2] UNIV CALIF LOS ANGELES, SCH MED, LOS ANGELES, CA USA
关键词
SURFACTANT; LUNG; INACTIVATION; INHIBITION; PHOSPHOLIPID; PULMONARY;
D O I
10.1016/0005-2760(93)90143-W
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Several mechanisms for surfactant inactivation have been reported. In this study, we have measured the reversibility of surfactant inactivation caused by various lipid or protein constituents of plasma or by pH changes. A surfactant of bovine origin was studied in a pulsating surfactometer either when surfactants were premixed with different serum constituents (inactivators) or when inactivators were introduced into subphase fluid surrounding surfactant films formed at an air-liquid interface. Subphase exchanges with sodium bicarbonate or sodium borate raised pH and raised minimal surface tensions either when premixed with surfactant or when introduced with saline subphase beneath a preformed surfactant surface film. The pH effects on surfactant film function were reversible for sodium bicarbonate but not for sodium borate when the subphase with bicarbonate or borate was replaced with saline. Lipids (platelet-activating factor or lysophosphatidylcholine) had non-reversible effects on preformed films. Proteins (fibrinogen or C reactive protein) had reversible effects at low concentrations, but reversibility was less evident at high concentrations. Effects with whole serum were non-reversible at low protein concentrations (0.5 mg/ml). These results add evidence that surfactant inactivation can be caused by multiple mechanisms, both reversible and irreversible.
引用
收藏
页码:321 / 326
页数:6
相关论文
共 42 条
  • [1] INHIBITION OF MIXTURES OF SURFACTANT LIPIDS AND SYNTHETIC SEQUENCES OF SURFACTANT PROTEINS SP-B AND SP-C
    AMIRKHANIAN, JD
    BRUNI, R
    WARING, AJ
    TAEUSCH, HW
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1096 (04) : 355 - 360
  • [2] COMPLEXING OF BACTERIAL LIPOPOLYSACCHARIDE WITH LUNG SURFACTANT
    BROGDEN, KA
    CUTLIP, RC
    LEHMKUHL, HD
    [J]. INFECTION AND IMMUNITY, 1986, 52 (03) : 644 - 649
  • [3] CHARON A, 1989, PEDIATRICS, V83, P348
  • [4] CLEMENTS JA, 1965, RESPIRATION, P1545
  • [5] PULMONARY SURFACTANT PROTEIN-B (SP-B) - STRUCTURE-FUNCTION-RELATIONSHIPS
    COCHRANE, CG
    REVAK, SD
    [J]. SCIENCE, 1991, 254 (5031) : 566 - 568
  • [6] PULMONARY SURFACTANT-ASSOCIATED PROTEIN-A ENHANCES THE SURFACE-ACTIVITY OF LIPID EXTRACT SURFACTANT AND REVERSES INHIBITION BY BLOOD PROTEINS INVITRO
    COCKSHUTT, AM
    WEITZ, J
    POSSMAYER, F
    [J]. BIOCHEMISTRY, 1990, 29 (36) : 8424 - 8429
  • [7] A CONTROLLED CLINICAL COMPARISON OF 4 DIFFERENT SURFACTANT PREPARATIONS IN SURFACTANT-DEFICIENT PRETERM LAMBS
    CUMMINGS, JJ
    HOLM, BA
    HUDAK, ML
    HUDAK, BB
    FERGUSON, WH
    EGAN, EA
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1992, 145 (05): : 999 - 1004
  • [8] 2 HYDROPHOBIC LOW-MOLECULAR-MASS PROTEIN-FRACTIONS OF PULMONARY SURFACTANT - CHARACTERIZATION AND BIOPHYSICAL ACTIVITY
    CURSTEDT, T
    JORNVALL, H
    ROBERTSON, B
    BERGMAN, T
    BERGGREN, P
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1987, 168 (02): : 255 - 262
  • [9] DRICKAMER K, 1986, J BIOL CHEM, V261, P6878
  • [10] ARTIFICIAL PULMONARY SURFACTANT INHIBITED BY PROTEINS
    FUCHIMUKAI, T
    FUJIWARA, T
    TAKAHASHI, A
    ENHORNING, G
    [J]. JOURNAL OF APPLIED PHYSIOLOGY, 1987, 62 (02) : 429 - 437